Research Reports

Key takeaways

Murat Kalayoglu, M.D., Ph.D. resigning from Board effective March 31, 2026.

Served on Board since 2023 as Chairman of Science and Technology Committee and member of Nominating and Corporate Governance Committee.

Resignation to pursue other opportunities, not due to any disagreement with Company.

Will cease service on both committees upon resignation.

Company thanks him for advice and leadership.

Full analysis

The resignation of Murat Kalayoglu from the Board of Directors of Cartesian Therapeutics, Inc., effective March 31, 2026, removes a key figure who has served since 2023 in significant oversight roles, including as Chairman of the Science and Technology Committee and a member of the Nominating and Corporate Governance Committee. This change occurs without any reported disagreements on operations, policies, or practices, suggesting continuity in board dynamics. Investors may note the loss of his expertise in science and technology governance, though the Company expresses appreciation for his contributions and well-wishes for his future endeavors.

RNAC · Cartesian Therapeutics, Inc.

Summary

Key takeaways

Full analysis